Entacapone and concomitant disease progression Patient Reports February 12, 2012

Entacapone Side Effects Report #5488311-2
Entacapone side effect was reported by a Physician from JAPAN on Sept 19, 2007. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease , gastric ulcer, dyspepsia, constipation , haemorrhoids and was treated with Entacapone. After drug was administered, patient experienced the following side effects: cardiac arrest , concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention. Entacapone dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON, POSTERISAN. Patient was hospitalized. Patient died on 09/29/2007.

Entacapone Side Effects Report #5501531-3
Entacapone side effect was reported by a Physician from JAPAN on Oct 23, 2007. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease , gastric ulcer, dyspepsia, constipation , haemorrhoids and was treated with Entacapone. After drug was administered, patient experienced the following side effects: cardiac arrest , concomitant disease progression, dysphagia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest, sputum retention. Entacapone dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON, POSTERISAN. Patient was hospitalized. Patient died on 09/29/2007.

Entacapone Side Effects Report #5670521-2
Entacapone side effect was reported by a Physician from JAPAN on Mar 13, 2008. Male patient, 74 years of age, weighting 101.4 lb, was diagnosed with parkinson's disease , gastric ulcer, dyspepsia, constipation  and was treated with Entacapone. After drug was administered, patient experienced the following side effects: cardiac arrest , concomitant disease progression, dysphagia, insomnia, metastases to lymph nodes, oesophageal carcinoma, oesophageal stenosis, oral intake reduced, respiratory arrest. Entacapone dosage: 200MG QID (800MG/DAY). During the same period patient was treated with FAMOTIDINE, SEVEN EP, MUCOSTA, EC DOPARL, MAGNESIUM OXIDE, LECICARBON. Patient was hospitalized. Patient died on 09/29/2007.